Sponsor Pipeline

LIANG WANG Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
0
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07457177 Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL NK T-Cell Lymphoma Not Yet Recruiting
Get alerts when LIANG WANG's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free